Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Opus Genetics (IRD) Return on Equity (2019 - 2026)

Opus Genetics has reported Return on Equity over the past 12 years, most recently at 0.07% for Q1 2026.

  • Quarterly Return on Equity rose 17.0% to 0.07% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.07% through Mar 2026, up 17.0% year-over-year, with the annual reading at 0.04% for FY2025, 2.0% down from the prior year.
  • Return on Equity was 0.07% for Q1 2026 at Opus Genetics, up from 0.05% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.07% in Q1 2026 and troughed at 0.1% in Q1 2025.
  • The 5-year median for Return on Equity is 0.01% (2024), against an average of 0.01%.
  • Year-over-year, Return on Equity plummeted -34bps in 2022 and then grew 17bps in 2026.
  • A 5-year view of Return on Equity shows it stood at 0.01% in 2022, then plummeted by -132bps to 0.0% in 2023, then tumbled by -1307bps to 0.03% in 2024, then tumbled by -66bps to 0.05% in 2025, then surged by 251bps to 0.07% in 2026.
  • Per Business Quant, the three most recent readings for IRD's Return on Equity are 0.07% (Q1 2026), 0.05% (Q4 2025), and 0.06% (Q3 2025).